Posts in LSE:TSTL

These stellar small-cap stocks could be good for your wealth

Searching for confirmation on the merits of small-cap investing? Look no further than infection prevention product manufacturer Tristel (LSE:TSTL). Over the last five years, the price of its stock has more than seven-bagged. While many would consider this kind of return to be more than sufficient, today's full-year results suggest there's still considerable upside ahead.

Broker Forecast - finnCap issues a broker note on Tristel PLC

finnCap today reaffirms its corporate investment rating on Tristel PLC (LON:TSTL) and set its price target at 275p.

Tristel boosted by strong overseas operations

Tristel, a manufacturer of infection prevention and contamination control products, grew its turnover by 19% to £20.3 million in the year ended 30 June, ahead of expectations.

Overseas sales rose by 43% to £9.6 million, representing 47% of total sales compared with 39% the year before.

Pre-tax profit before share-based payments increased by 24% to £4.1 million.

The company has lifted its full year dividend by 21% to 4.03p.

Paul Swinney, chief executive of Tristel, said: "We are pleased with the progress made this year.

Tristel expects EPA decision delay

Tristel said approval from the United States Environmental Protection Agency for its foam-based chlorine dioxide product DUO will come later than it had originally expected.

EPA approval is now anticipatd in May, 2008, rather than late in 2007.

The delay comes after the agency informed Tristel that it needed additional information to complete its assessment.

The additional data has largely been completed and submitted, Tristel said.

At 9:38am: (LON:TSTL) Tristel PLC share price was -22.5p at 250p

Small Cap Breakfast 03/10/2017

Breakfast buffet Breakfast buffet Breakfast buffet Breakfast buffet Metal Tiger (MTR.L) 1.82p £18m The investor in strategic natural resource opportunities, provided an update regarding the Company’s Joint Venture project with partners MOD Resources (ASX:MOD) in the Kalahari Copper Belt in Botswana (70% MOD Resources/30% Metal Tiger). Drilling has intersected new zones of visible copper mineralisation 300m west and northeast of planned pit. Copper mineralisation now extends over a strike length of 1.5km and remains open. Seven drill rigs now operating at T3, diamond core drilling progressing well. Prefeasibility Study now modelling a 2.5Mtpa processing rate, up 25% compared to the Scoping Study. Excellent metallurgical testwork results received. Deltex Medical Group (DEMG.L) 3.25p £10.18m The specialist “in Oesophageal Doppler Monitoring ("ODM"), to announced the addition of a significant new hospital account in the USA. The new account is a 600 bed teaching hospital which initially plans to treat around 40 patients per month within its surgical enhanced recovery programmes. After the hospital's positive clinical evaluation of ODM was completed in the first half of 2015, implementation was delayed pending a hospital system merger. As a result of the combination, there are now ten further hospitals in the enlarged system. The procurement agreement covers the whole system, providing scope for relatively rapid conversion of future clinical acceptance of ODM into incremental revenues.” FYDec17E rev £6.77m and £1.74m PBT. Inspiration Healthcare (IHC.L) 63.5p £19.47m “The global medical device company, today announces that NeuroproteXeon Limited ("NeuroproteXeon), in which Inspiration Healthcare has a 8.1% fully diluted shareholding, has secured a licence agreement with Mallinckrodt plc (NYSE:MNK) for the development and commercialisation of NeuroproteXeon's investigational, pharmaceutical-grade xenon gas for inhalation therapy. Under the terms of the agreement, a subsidiary of NeuroproteXeon will receive an upfront payment of $10m in cash from Mallinckrodt, with potential additional payments of up to $25m dependent on developmental, regulatory and sales milestones. In addition, NeuroproteXeon will receive tiered royalties on applicable worldwide product sales and a transfer price for commercial product supply.” Hargreaves Services (HSP.L) 338.88p £108.14m AGM statement from the diversified group delivering key projects and services in the infrastructure, energy and property sectors. “The Board is pleased to announce that trading, both at Group level and in its Services and Distribution division, is in line with expectations. In its Property Division, the development of Blindwells, a major housing development in East Lothian, is progressing well and in line with expectations. We are also pleased to note that sale processes are advancing for a number of other material properties and although timing of such sales remains hard to forecast, the Board is encouraged with progress and activity levels. The Board is also pleased to announce that John Samuel has been recruited to succeed Iain Cockburn as Group Finance Director when Iain moves to join Brockwell Energy in a full-time capacity.” FYMay18E rev £323m and £6.65m PBT. RedT Energy (RED.L) 10.37p £67.84m “The energy storage technology company, is pleased to announce the sale of a 300kW 1MWh hybrid energy storage system for Monash University in Melbourne, Australia. This is the first time a vanadium flow / lithium hybrid energy storage system has been deployed in Australia and marks redT's entry into the burgeoning Australian market for energy storage which we currently estimate at between AUD $20-30bn, up to 2030. The system, which comprises 900kWh of redT flow machines coupled with a 120kW C1-rated lithium battery, will be deployed as an active energy storage infrastructure asset at the University's new 11,400 m2 Biomedical Learning and Teaching building, which will house state-of-the-art biomedical research laboratories over 4 floors.  Coupled with on-site solar PV assets, the system will be used to maximise the university's utilisation of renewable energy to significantly reduce energy costs for campus buildings.” FYDec17E rev £11.34m and PBT loss £7.5m. Independent Oil & Gas (IOG.L) 15p £15.84m “The development and production focused Oil and Gas Company, is pleased to announce that it has signed a Letter of Intent ("LOI") with Heerema Fabrication Group.  ("Heerema") for Front End Engineering and Design ("FEED") and Engineering, Procurement, Construction and Installation ("EPCI") of up to four Normally Unmanned Installation platforms ("NUIs").   Highlights: ·    The NUIs will be utilised for IOG's Southern North Sea (SNS) gas project, which consists of the Blythe Hub and Vulcan Satellites Hub developments. ·     FEED costs will be fully deferred and EPCI costs are to be 50% deferred. ·   The LOI is a further demonstration of our commercial model aligning the incentives of all project partners.” AB Dynamics (ABD.L) 577.5p £110.85m FYAug12 trading statement from the designer, manufacturer and supplier of advanced testing systems and measurement products to the global automotive industry. The Group has performed well in 2017 and the Board expects revenue and profit before tax (excluding share option charges and latest IFRS 15 adjustments) to be slightly ahead of analysts' forecasts. The Board has chosen early adoption of IFRS 15, from 1 March 2017, and this is expected to lead to a reduction in the level of reported revenue for the year to 31 August 2017, but with no consequential impact on profit before tax. Despite the adoption of IFRS 15, it is anticipated that reported revenue will nevertheless remain in-line with current market expectations.  FUAug17E rev £24.4m and £5.1m PBT. Oxford Biodynamics (OBD.L) 193.38p £166.49m The “biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, today announces the grant of a key patent in the United States by the US Patent and Trademark Office (USPTO) covering EpiSwitch™, the Company's novel technology platform.  The US patent, number 9777327, covers OBD's proprietary EpiSwitch™ technology designs for high resolution discovery and monitoring of regulatory conditional chromosome conformation signatures, as part of the regulatory genome architecture. As a biomarker modality, chromosome conformations have been shown to deliver highly informative stratifications of complex patient phenotypes, assist in better disease understanding and target identifications, and show high concordance with complex genetic and gene expression profiles.” Firestone Diamonds (FDI.L)57p £67.7m The “diamond mining company, is pleased to announce the recovery of its largest diamond to date, a 134 carat gem-quality light yellow diamond, from its Liqhobong Diamond Mine, located in Lesotho.  The Board believes this recovery, the second of over a hundred carats since production commenced, reinforces the potential for large stones at Liqhobong as the Company continues early stage mining.” FYJun18E rev £68.04m and £0.51m loss, Tristel (TSTL.L) 272.5p £116.78m “The manufacturer of infection prevention, contamination control and hygiene products, announces a change to the expected approval date from the United States Environmental Protection Agency (EPA) for its foam based chlorine dioxide product DUO.  A meeting with the EPA in October 2016 and subsequent communications with the agency guided the scope and content of the Company's Duo submission which was made on 30 June 2017.  The EPA has now informed the Company that it has changed its approach and additional information has been requested. This additional data has largely been compiled and submitted. As a result, the EPA approval is now expected in May 2018, rather than late 2017 as originally anticipated. Approval will be followed by the state by state registration process and the Company's revenue expectations are not affected by this slight delay.” FYJun18E rev £22.4m and £4.4m PBT.
hybridan
a9b2f260-b02b-47fc-9772-8995881199a3
No
https://indigo.bluematrix.com/indigo/Viewer.action?info=kK07jdZm7EHRmu%2BkNGsusOwK6N5wpm5U
Tristel Plc

Why AIM could miss out on the next ASOS

Why AIM could miss out on the next ASOS

AIM is there to provide opportunities, but former AIM writer of the year Andrew Hore argues that a new idea currently being touted could make the junior market a poorer place.

Director Deals - Tristel PLC (TSTL)

Elizabeth Dixon, Financial Director, sold 10,000 shares in the company on the 16th August 2017 at a price of 273.00p. The Director now holds 45,000 shares.

Director deals data provided by www.directorsholdings.com

Broker Forecast - finnCap issues a broker note on Tristel PLC

finnCap today reaffirms its corporate investment rating on Tristel PLC (LON:TSTL) and raised its price target to 225p (from 195p).

Two smoking small-cap stocks I’ve added to my watchlist

The share prices of small caps Tristel (LSE:TSTL) and Marlowe (LSE:MRL) have seen stellar rises of late -- up 21% and 33% respectively over the last three months. Here's why I've added both to my watchlist.

Overseas growth

£91m cap Tristel is a manufacturer of infection control, contamination control and hygiene products. Based on today's encouraging trading update, I'm confident it won't remain a market minnow for much longer.

Tristel says pre-tax profit beat market expectations

Tristel announced both turnover and pre-tax profit are ahead of market expectations in the year to 30 June 2017.

Tristel will record turnover in excess of £20 million (2016: £17.1 million) and pre-tax profit (before share-based payments) of at least £4 million (2016: £3.3 million).

In the second half, revenue from overseas markets contributed 50% of the group total compared to 43% in the first half, and for the full year overseas revenue represented 47% of Group revenue - a record level.

Tristel continued to generate significant levels of cash and at 30 June 2017 cas